Analgesic efficacy and acceptability of tts - fentanyl (durogesic) in patients with advanced cancer: A prospective examination

被引：0
|
作者：
Iconomou, G [1 ]
Viha, A [1 ]
Kalofonos, HP [1 ]
Vagenakis, A [1 ]
机构：
[1] Univ Patras, Sch Med, Dept Med Oncol, GR-26110 Patras, Greece
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81913-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1499
引用
收藏
页码：S369 / S369
页数：1
相关论文
共 50 条
  • [1] Transdermal fentanyl in cancer patients with moderate-to-severe pain: A prospective examination
    Iconomou, G
    Viha, A
    Vagenakis, AG
    Kalofonos, HP
    ANTICANCER RESEARCH, 2000, 20 (6C) : 4821 - 4824
  • [2] Patients' Acceptability of Different Fentanyl Products for Breakthrough Cancer Pain
    Mercadante, S.
    Caruselliy, A.
    Meliz, M. R.
    Bellavia, G.
    Tuttolomondo, A.
    Casuccio, A.
    CLINICAL ONCOLOGY, 2014, 26 (12) : 806 - 806
  • [3] Tolerability, efficacy and acceptability of fentanyl pectin nasal spray for breakthrough cancer pain
    Massimiliano, A.
    Bronte, G.
    Spataro, F. P.
    Bronte, E.
    Leonardi, V. B.
    Usset, A.
    Laudani, A.
    Arcuri, C.
    Cusimano, M. P.
    Russo, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] Cost-effectiveness and cost-utility of fentanyl TTS (Durogesic® 25, 50) vs. SR/IR oral morphines in the management of chronic cancer pain
    Estevez-Carrizo, F. E.
    VALUE IN HEALTH, 2006, 9 (06) : A284 - A284
  • [5] Use of TTS fentanyl as a single opioid for cancer pain relief: A safety and efficacy clinical trial in patients naive to mild or strong opioids
    Mystakidou, K
    Befon, S
    Tsilika, E
    Dardoufas, K
    Georgaki, S
    Vlahos, L
    ONCOLOGY, 2002, 62 (01) : 9 - 16
  • [6] Treatment of chronic non-cancer patient with Fentanyl-TTs -: Results with 6797 patients
    Theodoridis, T
    Waap, I
    Schwalen, S
    Krämer, J
    ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE, 2003, 141 (03): : 245 - 249
  • [7] A small-dose intravenous fentanyl can predict the analgesic efficacy and the incidence of side effects in patients with epidural fentanyl
    Ueta, K
    Takeda, K
    Ohsumi, T
    Haruna, J
    Shibuya, H
    ANESTHESIOLOGY, 2000, 93 (3A) : U199 - U199
  • [8] Comparison of treatment initiation with transdermal fentanyl 12.5μg/h and transdermal fentanyl ≥ 25μg/h (Durogesic® SMAT) in patients with chronic non-cancer pain
    Bornhoevd, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 562 - 562
  • [9] Prospective examination of adrenocortical function in advanced AIDS patients
    Hoshino, Y
    Yamashita, N
    Nakamura, T
    Iwamoto, A
    ENDOCRINE JOURNAL, 2002, 49 (06) : 641 - 647
  • [10] MEANING-CENTERED PSYCHOTHERAPY FOR ADVANCED CANCER PATIENTS: AN EXAMINATION OF MODERATORS OF TREATMENT EFFICACY
    George, Login
    Rosenfeld, Barry
    Crespo, Iris
    -Breitbart, William
    ANNALS OF BEHAVIORAL MEDICINE, 2018, 52 : S686 - S686
12345